RUNX1 and ovarian serous adenocarcinoma: Western blot analysis revealed RUNX1 overexpression in high-grade serous ovarian cancer cell lines (SKOV3 and OVCAR3), compared to human normal ovarian epithelial cells (IOSE80) (Fig. 1E–F).